Zura Bio Limited - Class A — Quarterly Cash Flow (NASDAQ:ZURA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 189.07 M179.53 M172.5 M157.81 M143.94 M Total liabilities 18.24 M19.51 M21.09 M18.7 M25.49 M Total equity 154.59 M148.36 M139.74 M127.45 M109.78 M Total liabilities & shareholders' equities 189.07 M179.53 M172.5 M157.81 M143.94 M Total debt ————— Net debt —————

Haberler

Progress Software Posts Upbeat Q4 Earnings, Joins ServisFirst Bancshares, Zura Bio And Other Big Stocks Moving Higher On Wednesday - American Resources (NASDAQ:AREC), ARM Holdings (NASDAQ:ARM)

Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Ambarella (NASDAQ:AMBA), AST SpaceMobile (NASDAQ:ASTS)

Zura Bio expands HS trial, delays data readout to fourth quarter 2026

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI)

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Autolus Therapeutics (NASDAQ:AUTL), DigitalBridge Gr (NYSE:DBRG)

H.C. Wainwright reiterates Neutral rating on Zura Bio stock amid BAFF inhibitor concerns

Zura Bio names Eric Hyllengren as new CFO, effective July 7

Zura Bio to Present at the Jefferies Global Healthcare Conference

Zura Bio begins phase 2 trial for hidradenitis suppurativa treatment